BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32024603)

  • 1. Stereotactic Body Radiotherapy Versus Metastasectomy in Patients With Pulmonary Metastases From Soft Tissue Sarcoma.
    Tetta C; Londero F; Micali LR; Parise G; Algargoush AT; Algargoosh M; Albisinni U; Maessen JG; Gelsomino S
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):303-315. PubMed ID: 32024603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.
    Dhakal S; Corbin KS; Milano MT; Philip A; Sahasrabudhe D; Jones C; Constine LS
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):940-5. PubMed ID: 21277105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
    Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
    Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas.
    Frakulli R; Salvi F; Balestrini D; Parisi A; Palombarini M; Cammelli S; Rocca M; Salone M; Longhi A; Ferrari S; Morganti AG; Frezza G
    Anticancer Res; 2015 Oct; 35(10):5581-6. PubMed ID: 26408729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases.
    Lee YH; Kang KM; Choi HS; Ha IB; Jeong H; Song JH; Jang IS; Kim SH; Lee JW; Rhee DY; Jeong BK
    Thorac Cancer; 2018 Dec; 9(12):1671-1679. PubMed ID: 30298701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of surgical resection of lung metastases from soft tissue sarcoma: A single center experience.
    Nevala R; Jäämaa S; Tukiainen E; Tarkkanen M; Räsänen J; Blomqvist C; Sampo M
    J Surg Oncol; 2019 Aug; 120(2):168-175. PubMed ID: 31134646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary metastasectomy for soft tissue sarcoma--report from a dual institution experience at the Medical University of Vienna.
    Schur S; Hoetzenecker K; Lamm W; Koestler WJ; Lang G; Amann G; Funovics P; Nemecek E; Noebauer I; Windhager R; Klepetko W; Brodowicz T
    Eur J Cancer; 2014 Sep; 50(13):2289-97. PubMed ID: 24997493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma.
    Chudgar NP; Brennan MF; Munhoz RR; Bucciarelli PR; Tan KS; D'Angelo SP; Bains MS; Bott M; Huang J; Park BJ; Rusch VW; Adusumilli PS; Tap WD; Singer S; Jones DR
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):319-330.e1. PubMed ID: 28395901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma.
    Kawamoto T; Hara H; Morishita M; Fukase N; Kawakami Y; Takemori T; Fujiwara S; Kitayama K; Yahiro S; Miyamoto T; Fujimoto T; Fujita I; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
    Clin Exp Metastasis; 2020 Aug; 37(4):509-517. PubMed ID: 32436018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors.
    Kanzaki R; Suzuki O; Kanou T; Ose N; Funaki S; Shintani Y; Minami M; Tamari K; Otani K; Seo Y; Isohashi F; Ogawa K; Okumura M
    J Cardiothorac Surg; 2020 Feb; 15(1):43. PubMed ID: 32103767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival following Pulmonary Metastasectomy for Sarcoma.
    Okiror L; Peleki A; Moffat D; Bille A; Bishay E; Rajesh P; Steyn R; Naidu B; Grimer R; Kalkat M
    Thorac Cardiovasc Surg; 2016 Mar; 64(2):146-9. PubMed ID: 25742552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma.
    Loi M; Duijm M; Baker S; Rossi L; Grunhagen D; Verhoef C; Nuyttens J
    Radiol Med; 2018 Nov; 123(11):871-878. PubMed ID: 29923086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma.
    Yamamoto Y; Kanzaki R; Kanou T; Ose N; Funaki S; Shintani Y; Minami M; Outani H; Takenaka S; Hamada K; Yoshikawa H; Okumura M
    Int J Clin Oncol; 2019 Jul; 24(7):863-870. PubMed ID: 30806840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events.
    Inoue T; Oh RJ; Shiomi H; Masai N; Miura H
    Strahlenther Onkol; 2013 Apr; 189(4):285-92. PubMed ID: 23420546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary metastasectomy and repeat metastasectomy for soft-tissue sarcoma.
    Toussi MS; Bagheri R; Dayani M; Anvari K; Sheibani S
    Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):437-42. PubMed ID: 24570526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-surgical Treatments for Lung Metastases in Patients with Soft Tissue Sarcoma: Stereotactic Body Radiation Therapy (SBRT) and Radiofrequency Ablation (RFA).
    Tetta C; Carpenzano M; Algargoush ATJ; Algargoosh M; Londero F; Maessen JG; Gelsomino S
    Curr Med Imaging; 2021; 17(2):261-275. PubMed ID: 32819261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
    Baumann BC; Bernstein KA; DeLaney TF; Simone CB; Kolker JD; Choy E; Levin WP; Weber KL; Muniappan A; Berman AT; Staddon A; Hartner L; Van Tine B; Hirbe A; Glatstein E; Hahn SM; Nagda SN; Chen YL
    J Surg Oncol; 2020 Oct; 122(5):877-883. PubMed ID: 32588468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival after pulmonary metastasectomy for soft tissue sarcoma.
    Predina JD; Puc MM; Bergey MR; Sonnad SS; Kucharczuk JC; Staddon A; Kaiser LR; Shrager JB
    J Thorac Oncol; 2011 May; 6(5):913-9. PubMed ID: 21750417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma.
    Dossett LA; Toloza EM; Fontaine J; Robinson LA; Reed D; Druta M; Letson DG; Zager JS; Gonzalez RJ
    J Surg Oncol; 2015 Jul; 112(1):103-6. PubMed ID: 26179670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.